Vir Biotechnology Inc’s filing revealed that its EVP, General Counsel, Corp Sec de Verneuil Vanina unloaded Company’s shares for reported $12307.0 on Nov 05 ’25. In the deal valued at $5.16 per share,2,385 shares were sold. As a result of this transaction, de Verneuil Vanina now holds 78,210 shares worth roughly $0.45 million.
Then, de Verneuil Vanina bought 2,385 shares, generating $12,307 in total proceeds.
Before that, de Verneuil Vanina sold 1,365 shares. Vir Biotechnology Inc shares valued at $8,003 were divested by the EVP and General Counsel at a price of $5.86 per share. As a result of the transaction, de Verneuil Vanina now holds 80,595 shares, worth roughly $0.46 million.
Evercore ISI initiated its Vir Biotechnology Inc [VIR] rating to an Outperform in a research note published on September 03, 2025; the price target was $12. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in late August from “a Neutral” to “a Buy”. JP Morgan also remained covering VIR and has decreased its forecast on January 29, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. BofA Securities revised its rating on September 08, 2023. It rated VIR as “a Neutral” which previously was an “a Buy”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock jump 6.33% to $5.71. Over the last five days, the stock has gained 8.76%. Vir Biotechnology Inc shares have fallen nearly -41.56% since the year began. Nevertheless, the stocks have fallen -22.21% over the past one year. While a 52-week high of $14.45 was reached on 01/08/25, a 52-week low of $4.16 was recorded on 08/11/25.
Levels Of Support And Resistance For VIR Stock
The 24-hour chart illustrates a support level at 5.45, which if violated will result in even more drops to 5.19. On the upside, there is a resistance level at 5.85. A further resistance level may holdings at 6.00.
How much short interest is there in Vir Biotechnology Inc?
A steep rise in short interest was recorded in Vir Biotechnology Inc stocks on 2025-10-31, dropping by -1.37 million shares to a total of 9.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 10.95 million shares. There was a decline of -14.27%, which implies that there is a negative sentiment for the stock.
